CLINICAL_TRIALS
trial_result
· 2022-05-05
Clinical Trial Update: Role of Fexofenadine in Diabetic Kidney Disease [Phase 3]
Summary
Phase 3 clinical trial evaluating fexofenadine in diabetic kidney disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanta University | Conditions: Diabetic Kidney Disease | Phase 3 | Status: COMPLETED